Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19

BACKGROUND: There is no proven antiviral or immunomodulatory therapy for coronavirus disease 2019 (COVID-19). The disease progression associated with the proinflammatory host response prompted us to examine the role of early corticosteroid therapy in patients with moderate to severe COVID-19. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadel, Raef, Morrison, Austin R, Vahia, Amit, Smith, Zachary R, Chaudhry, Zohra, Bhargava, Pallavi, Miller, Joseph, Kenney, Rachel M, Alangaden, George, Ramesh, Mayur S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314133/
https://www.ncbi.nlm.nih.gov/pubmed/32427279
http://dx.doi.org/10.1093/cid/ciaa601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314133/
https://www.ncbi.nlm.nih.gov/pubmed/32427279
http://dx.doi.org/10.1093/cid/ciaa601

Ejemplares similares